BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11243418)

  • 1. Hemodynamic and electrocardiographic effects of almotriptan in healthy volunteers.
    Boyce M; Dunn K; Warrington S
    J Cardiovasc Pharmacol; 2001 Mar; 37(3):280-9. PubMed ID: 11243418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular effect of almotriptan in treated hypertensive patients.
    Fleishaker JC; McEnroe JD; Azie NE; Francom SF; Carel BJ
    Clin Pharmacol Ther; 2002 Mar; 71(3):169-75. PubMed ID: 11907491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of electrocardiographic and hemodynamic effects of caffeine with acute dosing in healthy volunteers.
    Ammar R; Song JC; Kluger J; White CM
    Pharmacotherapy; 2001 Apr; 21(4):437-42. PubMed ID: 11310517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular safety profile of almotriptan, a new indolic derivative for the treatment of migraine.
    Gras J; Cardelús I; Llenas J; Palacios JM
    Eur J Pharmacol; 2000 Dec; 410(1):53-9. PubMed ID: 11134656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of High Volume Energy Drink Consumption on Electrocardiographic and Blood Pressure Parameters: A Randomized Trial.
    Shah SA; Szeto AH; Farewell R; Shek A; Fan D; Quach KN; Bhattacharyya M; Elmiari J; Chan W; O'Dell K; Nguyen N; McGaughey TJ; Nasir JM; Kaul S
    J Am Heart Assoc; 2019 Jun; 8(11):e011318. PubMed ID: 31137991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Single and Multiple Energy Shots on Blood Pressure and Electrocardiographic Parameters.
    Shah SA; Dargush AE; Potts V; Lee M; Millard-Hasting BM; Williams B; Lacey CS
    Am J Cardiol; 2016 Feb; 117(3):465-8. PubMed ID: 26708636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics and effects on blood pressure of multiple doses of the novel anti-migraine drug zolmitriptan (311C90) in healthy volunteers.
    Dixon R; Gillotin C; Gibbens M; Posner J; Peck RW
    Br J Clin Pharmacol; 1997 Mar; 43(3):273-81. PubMed ID: 9088582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Almotriptan: a review of its use in migraine.
    Keam SJ; Goa KL; Figgitt DP
    Drugs; 2002; 62(2):387-414. PubMed ID: 11817980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spotlight on almotriptan in migraine.
    Keam SJ; Goa KL; Figgitt DP
    CNS Drugs; 2002; 16(7):501-7. PubMed ID: 12056924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral almotriptan vs. oral sumatriptan in the abortive treatment of migraine: a double-blind, randomized, parallel-group, optimum-dose comparison.
    Spierings EL; Gomez-Mancilla B; Grosz DE; Rowland CR; Whaley FS; Jirgens KJ
    Arch Neurol; 2001 Jun; 58(6):944-50. PubMed ID: 11405809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrocardiographic and hemodynamic effects of coenzyme Q10 in healthy individuals: a double-blind, randomized controlled trial.
    Shah SA; Sander S; Cios D; Lipeika J; Kluger J; White CM
    Ann Pharmacother; 2007 Mar; 41(3):420-5. PubMed ID: 17341532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrocardiographic and hemodynamic effects of Panax ginseng.
    Caron MF; Hotsko AL; Robertson S; Mandybur L; Kluger J; White CM
    Ann Pharmacother; 2002 May; 36(5):758-63. PubMed ID: 11978148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring the effects of supratherapeutic doses of levofloxacin on healthy volunteers using four methods of QT correction and periodic and continuous ECG recordings.
    Noel GJ; Goodman DB; Chien S; Solanki B; Padmanabhan M; Natarajan J
    J Clin Pharmacol; 2004 May; 44(5):464-73. PubMed ID: 15102866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between ketoconazole and almotriptan in healthy volunteers.
    Fleishaker JC; Herman BD; Carel BJ; Azie NE
    J Clin Pharmacol; 2003 Apr; 43(4):423-7. PubMed ID: 12723463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic interaction between verapamil and almotriptan in healthy volunteers.
    Fleishaker JC; Sisson TA; Carel BJ; Azie NE
    Clin Pharmacol Ther; 2000 May; 67(5):498-503. PubMed ID: 10824628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective analysis of electrocardiographic changes after administration of oral or intravenous garenoxacin in five phase I, placebo-controlled studies in healthy volunteers.
    Wang Z; Grasela DM; Krishna G
    Clin Ther; 2007 Jun; 29(6):1098-106. PubMed ID: 17692724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic and humoral effects at rest and after head-up tilt tests during 24-hour infusion of a new nitrate ester, ITF 296, compared with ISDN and placebo in healthy volunteers: a double-blind, randomized, within-subject study.
    Sardina M; Warrington SJ; Boyce M; Johnston A; Bianchini C
    J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S80-90. PubMed ID: 8839231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrocardiographic and blood pressure effects of energy drinks and Panax ginseng in healthy volunteers: A randomized clinical trial.
    Shah SA; Occiano A; Nguyen TA; Chan A; Sky JC; Bhattacharyya M; O'Dell KM; Shek A; Nguyen NN
    Int J Cardiol; 2016 Sep; 218():318-323. PubMed ID: 27240158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Phase 1, double-blind, 4-period crossover study to investigate the effects of pomalidomide on QT interval in healthy male subjects.
    Mondal SA; Assaf M; Liu L; O'Mara E
    Cancer Chemother Pharmacol; 2016 Feb; 77(2):251-8. PubMed ID: 26754679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of new generation triptans - frovatriptan and almotriptan - on hemodynamic parameters in intact male and female rats.
    Saracheva K; Hrischev P; Vasileva L; Topolov M; Nikolova J; Getova D
    Acta Pharm; 2020 Jun; 70(2):239-247. PubMed ID: 31955146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.